Three developments, three delivery pathways
Vitens’ development agenda includes a modification to an existing treatment asset, a partnership for a future drinking-water concept and a smart-meter trial. Deventer, Living Lab Strategic Heart and Westeinde illustrate different ways to improve supply and service. Their significance comes from what each activity changes and its reported stage, rather than from treating every announcement as new operating capacity.
Deventer: change within an existing permit
Vitens reported that production capacity at Deventer was expanded in 2024 by modifying the treatment plant within its current permit. This is a dated account of change to an existing asset. The accepted evidence gives no numerical capacity increase, so it supports the nature and timing of the modification without a quantified addition to company-wide supply.
That route matters alongside the company’s statement that a new water abstraction currently takes more than 20 years to become operational. Treatment modification and new resource access have different delivery requirements. The reported Deventer work shows one existing-asset pathway; it is not evidence that permitting or resource constraints have been resolved throughout the system.
Living Lab Strategic Heart: developing the concept
On June 16, 2023 Vitens announced a five-year building-team partnership with a consortium to develop a future drinking-water concept through Living Lab Strategic Heart. The associated pilot installation was planned at 5 to 10 million m³ per year. This range establishes the intended scale of the pilot, while the partnership identifies the collaborative delivery arrangement.
The reported stage is development: neither the five-year partnership nor the planned capacity establishes a commissioning date, achieved output or commercial operation. The next useful evidence would concern the transition from concept and pilot preparation to a commissioned installation, with operating results on a stated basis. Until then, the range remains separate from the 352.9 million m³ actually delivered to customers in 2025.
Westeinde: testing the service technology
The Westeinde smart water meter trial in Leeuwarden concerns the customer-service side of the system. The retained company account describes practical testing since 2019, with hourly transmission of readings in more than 1,500 households and various businesses. This tests a way of obtaining more frequent consumption information, rather than adding abstraction or treatment capacity.
Wider rollout depended on the test results. Because the account is undated, it is evidence of the described trial rather than a measurement of company-wide deployment in 2025 or 2026. Its delivery question is whether the tested approach earns wider adoption; that differs from the commissioning question facing a production pilot.
The investment context
Net investment rose from €157.6 million in 2020 to €341.5 million in 2025 in the annual report’s comparable six-year row, excluding contributions from new connections. This growing annual investment flow provides context for development activity. It does not allocate a project budget to Deventer, Living Lab or the meter trial, so their financial requirements cannot be inferred from the company total.
The practical reading is to follow each development through its own evidence: the reported treatment modification, the planned pilot and the result-dependent technology rollout. This keeps attention on actual delivery progress while preserving the distinction between an operating change, a development concept and a trial.
Questions for closer reading
What evidence would show that the Living Lab has moved beyond a plan?
A dated commissioning record and actual operating results would address a different stage from the partnership announcement and planned capacity. The accepted account establishes neither. Readers should look for that transition instead of assuming the partnership duration is an opening schedule.
Why keep the meter trial separate from production projects?
Its stated function is hourly customer-reading transmission and practical testing. Its wider rollout depends on results, whereas a production project concerns treatment or supply capability. Separating those functions makes the delivery milestone for each development clearer.